A pharmacoeconomic evaluation of piperacillin/tazobactam versus meropenem in the treatment of adult febrile neutropenia

Journal of Medical Economics

Volumn 5, Issue 135-145, 2002, Pages 135-145

  Smyth, E T M ^a   Barr, J G ^a   Hogg, G M ^a   Oppenheim, B A ^b  

^a ROYAL VICTORIA HOSPITAL   (United Kingdom)

^b BIRMINGHAM HEARTLANDS HOSPITAL   (United Kingdom)

Author keywords

Meropenem; Monotherapy; Neutropenia; Pharmacoeconomics; Piperacillin tazobactam

Indexed keywords

ACICLOVIR; AMPHOTERICIN B; ANTIINFECTIVE AGENT; CEFTAZIDIME; CIPROFLOXACIN; CLINDAMYCIN; COLISTIN; COTRIMOXAZOLE; FLUCLOXACILLIN; FLUCONAZOLE; GENTAMICIN; IMIPENEM; ITRACONAZOLE; KETOCONAZOLE; MEROPENEM; METRONIDAZOLE; NETILMICIN; PENICILLIN G; PIPERACILLIN PLUS TAZOBACTAM; TEICOPLANIN; VANCOMYCIN;

ADULT DISEASE; ANTIBIOTIC THERAPY; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG COST; DRUG EFFICACY; DRUG MIXTURE; FEBRILE NEUTROPENIA; HUMAN; MAJOR CLINICAL STUDY; MONOTHERAPY; PRESCRIPTION; RANDOMIZED CONTROLLED TRIAL;

EID: 0141998028     PISSN: 13696998     EISSN: None     Source Type: Journal    
DOI: 10.3111/200205135145     Document Type: Article

References (5)

1. Cometta A, Calandra T, Gaya H et al. Monotherapy with Meropenem versus combination therapy with ceftazidime plus amikacin as empiric therapy for fever in granulocytopenic patients with cancer. Antimicrobial Agents and Chemotherapy 1996; 40: 1108-1115.
2. Oppenheim BA, Morgenstern GR, Chang J et al. Safety and efficacy of piperacillin/tazobactam versus meropenem in the treatment of febrile neutropenia. Proceedings of 7th Conference of the Federation of Infection Societies 2000, P67, 52.
3. Smyth ETM, Barr JG, O'Neill CA, Hogg GM. An assessment of the hidden and total antibiotic costs of four parenteral cephalosporins. PharmacoEconomics 1995; 8: 540-550.
4. Smyth ETM, Barr JG, Hogg GM. An assessment of hidden costs on total prescribing costs of courses of meropenem and imipenem/cilastatin. British Journal of Medical Economics 1996; 10: 325-340.
5. Anatomical, Therapeutic, Chemical (ATC) Classification Index including Defined Daily Doses (DDD). WHO Collaborating Centre for Drug Statistical Methodology, 2000.